Your exit was written the year you formed the business.

Where it starts

A healthcare company exists before it is filed, and every document copies that first idea

A clinician sees the same failure in the same system for the fourth year running and decides to run it a better way. An engineer watches a nurse fight with a device on a night shift and starts sketching. An owner who has spent twenty years building a company begins to picture the year after they stop.

None of that is a legal event yet. All of it is the most important document the company will ever have. Every paper signed afterward is a copy of it, made by people who never read the original.

Of the last 38 owners who wrote to this firm, 19 were building a health-tech product and 16 were forming a practice. The other 3 were selling a company they had run for years (Bella Law inbound, April to August 2026). Those are three points on one life rather than three kinds of client, and the first point is the day the idea gets a legal body.

Building

A product that touches a clinical decision crosses a regulatory line the day it ships

A company in motion produces two things at once: data about patients, and decisions about their care. Every rule in this field attaches to one or the other. HIPAA attaches to the data the moment your system creates, receives, stores or sends protected health information for a covered entity. The FDA's device rules attach to the decision the moment your software tells a clinician something the clinician cannot independently check. That is the fourth of four tests in the agency's September 2022 clinical decision support guidance.

Neither rule announces itself. The engineering lead asks whether the whole thing is legal, and the honest answer comes back as it depends. That answer is usually right, and it is also useless, because a rule held as a line of text gives nobody anything to build against. So the team translates it themselves, carries the risk at every handoff, and the weeks go by while nobody ships.

The enforcement record shows where companies actually get caught. Of the HIPAA actions the Office for Civil Rights closed in 2025, 76% included a finding on a missing or inadequate risk analysis (HIPAA Journal, 2025). The agency rarely reached a clever violation. It reached the company that never wrote the document.

Some of the rule is not settled either, and the AI part is the clearest case. The FDA issued its guidance on AI-enabled device software functions in draft form in January 2025, and a draft is not settled law. A model that keeps learning after launch sits in an open space. A company building there needs the open question named in writing, along with the facts that would close it.

The firm's Digital Health and AI practice maps the system before it reads a statute. It writes one answer to each open question, with the facts the answer stands on. Then it rewrites the business associate agreements and data terms to match the stack you actually run. Your engineering lead is welcome on the first call.

A company that has done that work holds a file. A file, read by a stranger, has two faces.

Timing

The room to change the terms closes months before the closing

Negotiation has a season. The letter of intent settles most of what a sale is worth, and it is signed before diligence opens. Once a purchase agreement is circulating, the price is fixed and most of the terms are following it. A seller can still move an indemnity cap or an earn-out covenant only while the buyer wants the deal more than the seller needs it.

Most owners reach that window unprepared, and 68% of them have no documented exit plan (Exit Planning Institute, 2023). Sellers who have already been through it name two regrets, and both are about time. 81% wish they had spent longer preparing, and 40% wish they had sold one to two years earlier, when valuations were higher (UBS Investor Watch, 2023). Some sales never happen at all. Business brokers reported that 36% of their engagements ended without one (Pepperdine). Where owners named a reason, the most common was a gap over what the business was worth.

The rules move too, and they move on fixed dates that do not care where a seller is in the process. From September 1, 2025, a new or renewed Texas physician non-compete may run no longer than one year and no wider than five miles. The buyout may not exceed one year's salary (Tex. Bus. & Com. Code § 15.50, as amended by SB 1318). New York requires 30 days' notice to its Department of Health before a deal that adds $25 million or more to a health care entity's in-state revenue (N.Y. Pub. Health Law art. 45-A). A home health agency that changes majority ownership within 36 months of enrolling must enroll in Medicare again as a new provider (42 C.F.R. § 424.550).

Waiting costs nothing on the day you do it, because no deadline passes and no letter arrives, and that is why it stays the easy choice for years. The cost arrives later, at a table, in the hands of whoever is holding the pen.

Exit Planning Institute, National State of Owner Readiness, 2023. UBS Investor Watch, Wind in Your Sales, 2023: 539 US business owners with at least $1M in revenue, fielded April 2023. Pepperdine Graziadio Business School, Private Capital Markets Report, on broker-reported engagements that closed without a sale. Texas SB 1318, 89th Legislature, effective 2025-09-01. N.Y. Pub. Health Law §§ 4550 to 4552, effective 2023-08-01. 42 C.F.R. § 424.550(b).

Acquisition and Exit

Nothing in a sale is decided at the sale

The sentence started at the formation. When a buyer's counsel opens diligence on a healthcare company, the first folder holds the oldest documents. Those are the certificate of formation, the operating agreement, the cap table, the IP assignments, and the enrollment file. The buyer is reading them for the first time. The seller wrote them ten years ago and has not read them since.

The list of what surfaces is short and predictable, and it is the same list from the first month of the company.

• Ownership that cannot legally take the money now on the table, because the entity was never allowed to hold it.
• Equity with no vesting, still sitting with a co-founder who left in month four of year one.
• Code that a contractor wrote and still owns, because nobody signed an assignment.
• A physician paid a share of what their referrals bring in, which the Stark Law reaches on strict liability.
• An operating agreement that says nothing about a partner dying, retiring, or losing a license.
• Enrollment records that name one set of owners while the cap table names another.

Each of those was a choice made on a day when it cost nothing. The buyer cannot make the risk disappear, so it prices the risk and moves most of it back onto the seller through the documents. That arrives as a lower price, a larger escrow, a longer indemnity, a special indemnity for the physician compensation, or an earn-out in place of cash. None of that is hostile. A buyer that did not price risk would be a bad buyer.

The license follows the same rule. A Texas home health or hospice license does not transfer, and it becomes invalid on the date ownership changes. The buyer applies for its own license at least 30 days before the transfer (26 Tex. Admin. Code §§ 558.23, 558.25). A New York licensed home care agency needs approval of the Public Health and Health Planning Council before a new owner may operate. The owners named on the enrollment file at formation are examined again at every change of ownership after it.

The firm's Acquisition and Exit practice runs from exit readiness through the letter of intent, diligence, regulatory review, the purchase agreement, and the obligations that survive closing. The work is to get the price up, get the terms right, and protect the people who helped you build it.

The formation decides the exit, and the thought decides the formation. That is the reason to bring the firm in at any point on the line, and it is the reason the firm reads all three points at once. It has lived all three.